The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.
Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.
Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
2d
U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes ...
When you buy through our links, we may earn a commission. Learn more› By Dave Gershgorn Dave Gershgorn is a writer covering monitors, laptops, and tablets. He is a certified display calibrator ...
Continuous glucose monitors, or CGMs, are devices that track blood sugar in real-time and can tell wearers how their bodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback